Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 10.
doi: 10.1007/s00246-025-04019-9. Online ahead of print.

Optimal Strategy for Thromboprophylaxis in Fontan Circulation: A Systematic Review and Meta-analysis with a Focus on Ethnic Differences

Kyung-Jin Oh  1 , Jue Seong Lee  2 , Jae Hee Seol  3 , Hee Joung Choi  4 , Min Jung Cho  5 , Miyoung Choi  6 , Jin Young Song  7 , Jo Won Jung  8 , Jae Yoon Na  9 , Jin Ah Kim  10 , Soo-Jin Kim  11
Affiliations

Optimal Strategy for Thromboprophylaxis in Fontan Circulation: A Systematic Review and Meta-analysis with a Focus on Ethnic Differences

Kyung-Jin Oh et al. Pediatr Cardiol. .

Abstract

Fontan circulation alters cardiovascular hemodynamics to maintain circulation using a single ventricle, which may consequently increase the risk of thromboembolism. This highlights the need for effective thromboprophylaxis strategies. This study assessed optimal thromboprophylaxis regimens for patients with Fontan circulation through a comprehensive meta-analysis of literature focused on personalized, ethnicity-based approaches. PubMed, Embase, and Cochrane Library databases were searched to identify studies reporting the thromboembolic and bleeding outcomes of patients with Fontan circulation. Thirty reports-four randomized controlled trials and 26 cohort studies-were analyzed. Aspirin (risk ratio [RR], 0.46; 95% confidence interval [CI], 0.2-1.08; p = 0.07), warfarin (RR, 0.40; 95% CI, 0.24-0.65; p < 0.001), and direct oral anticoagulants (DOACs) (RR, 0.22; 95% CI, 0.01-7.57; p = 0.4) were compared with no antithrombotic therapy, and only warfarin use resulted in a statistically significant reduction in thromboembolic risk, whereas the effects of aspirin and DOACs were not statistically significant. In the East Asian subgroup, aspirin significantly decreased thromboembolic risk, compared with no intervention (RR, 0.31; 95% CI, 0.16-0.58; p < 0.001), and was significantly more effective than warfarin (RR, 0.57; 95% CI, 0.37-0.88; p = 0.01). Bleeding risk showed no significant between-group differences. Compared with no intervention, thromboprophylaxis in patients with Fontan circulation reduces thromboembolic risk. Although our findings should be carefully interpreted because of the limited data, they indicate that aspirin may be more effective than warfarin in East Asian patients, underscoring the need for further research into ethnicity-tailored thromboprophylaxis strategies.

Keywords: Acetylsalicylic acid; Anticoagulant; Asian population; Fontan circulation; Thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. Ethical Approval: Not applicable. Consent to Participate: Not applicable. Consent to Publish: Not applicable. Previous Presentations: This research was presented as a poster at the 74th Autumn Conference of the Korean Pediatric Society in 2024 (Seoul, Republic of Korea).

References

    1. Baumgartner H, De Backer J, Babu-Narayan SV et al (2021) 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J 42:563–645. https://doi.org/10.1093/eurheartj/ehaa554 - DOI - PubMed
    1. Rychik J, Atz AM, Celermajer DS et al (2019) Evaluation and management of children and adults with Fontan circulation: a scientific statement from the American heart association. Circulation 140:e234–e284. https://doi.org/10.1161/cir.0000000000000696 - DOI - PubMed
    1. Gewillig M, Brown SC (2016) The Fontan circulation after 45 years: update in physiology. Heart 102:1081–1086. https://doi.org/10.1136/heartjnl-2015-307467 - DOI - PubMed
    1. Idorn L, Jensen AS, Juul K et al (2013) Thromboembolic complications in Fontan patients: population-based prevalence and exploration of etiology. Pediatr Cardiol 34:262–272. https://doi.org/10.1007/s00246-012-0431-4 - DOI - PubMed
    1. Skubera M, Gołąb A, Sternalski T et al (2023) Thromboembolic complications in adult patients following the Fontan procedure: a multicenter study. J Clin Med 12:3465. https://doi.org/10.3390/jcm12103465 - DOI - PubMed - PMC